![Giacomo Salvadore](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Giacomo Salvadore worked as Vice President-Translational Medicine at ACADIA Pharmaceuticals, Inc. Dr. Salvadore worked as Chief Medical Officer at Alector, Inc. from 2025 to 2026.
Dr. Salvadore earned a doctorate from Università degli Studi di Roma Tor Vergata.
Eerdere bekende functies van Giacomo Salvadore
| Bedrijven | Functie | Einde |
|---|---|---|
| ALECTOR, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2026 |
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | - |
Opleiding van Giacomo Salvadore
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
4
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Università degli Studi di Roma Tor Vergata
 Università degli Studi di Roma Tor Vergata Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alector, Inc.
 Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
Kies MarketScreener 
